Only 5 years ago, the U.S. market for X-ray, mammography and contrast agents was valued at over $5 billion.

Bayer

The medical imaging equipment market includes X-rays, mammography as well as contrast agents and injectors. The market declined in 2009 due to the Deficit Reduction Act, which limited reimbursement for some imaging modalities. The global economic recession of 2008 to 2009 negatively impacted this diagnostics market; however iData’s market research expects it to continually grow.

Top players leading the market include:

Bracco
Bayer Healthcare Pharmaceuticals
Covidien
Fujifilm
GE Healthcare
Philips Healthcare
Siemens Healthcare

For a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2016, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios, view iData’s report entitled, “U.S. Market for X-Ray, Mammography and Contrast Agents”